Company intelligence / Profile preview

mesoestetic Pharma Group

Ownership: Private
Employees: ~232
Development stage: Other

Overview

mesoestetic has demonstrated efficacy of its depigmenting topical therapy in vitro using advanced imaging techniques. The company’s cosmeceuticals and medical devices are CE-marked and widely used in dermatology/aesthetic medicine. Its main research focuses are anti-aging and depigmentation.

Therapeutic areas: Dermatology
Modalities: Topical drugs (creams, gels, serums)Oral nutraceuticals (capsules, sachets)Class III medical devices for intradermal administration (mesotherapy)Energy-based medical aesthetic devices
Industry: Biotech

Drug pipeline

2 assets

mesohyal argibenone

Unknown

1 more asset in the full pipeline.

Partnerships

Collaborates with universities/research centers/scientific groups for biotechnology R&D.

Beyond the preview

Go deeper on mesoestetic Pharma Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on mesoestetic Pharma Group.